ConductScience.org, home

Trial · NCT02717455

Adverse events666

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousMuscle weakness right-sidedMusculoskeletal and connective tissue disordersStratum 2, Dose Level 1 (16 mg/m^2)030
seriousMuscle weakness right-sidedMusculoskeletal and connective tissue disordersStratum 2, Dose Level 2 (22 mg/m^2)0110
seriousMuscle weakness right-sidedMusculoskeletal and connective tissue disordersStratum 2, Dose Level 3 (28 mg/m^2)0120
seriousMuscle weakness right-sidedMusculoskeletal and connective tissue disordersStratum 2, Dose Level 4 (36 mg/m^2)060
seriousTrismusMusculoskeletal and connective tissue disordersStratum 1, Dose Level 1 (10 mg/m^2)0130
seriousTrismusMusculoskeletal and connective tissue disordersStratum 1, Dose Level 2 (16 mg/m^2)060
seriousTrismusMusculoskeletal and connective tissue disordersStratum 2, Dose Level 1 (16 mg/m^2)030
seriousTrismusMusculoskeletal and connective tissue disordersStratum 2, Dose Level 2 (22 mg/m^2)1111
seriousTrismusMusculoskeletal and connective tissue disordersStratum 2, Dose Level 3 (28 mg/m^2)0120
seriousTrismusMusculoskeletal and connective tissue disordersStratum 2, Dose Level 4 (36 mg/m^2)060
seriousNeoplasms benign, malignant and unspecified (incl cysts and polyps) - other, specifyNeoplasms benign, malignant and unspecified (incl cysts and polyps)Stratum 1, Dose Level 1 (10 mg/m^2)6138
seriousNeoplasms benign, malignant and unspecified (incl cysts and polyps) - other, specifyNeoplasms benign, malignant and unspecified (incl cysts and polyps)Stratum 1, Dose Level 2 (16 mg/m^2)161
seriousNeoplasms benign, malignant and unspecified (incl cysts and polyps) - other, specifyNeoplasms benign, malignant and unspecified (incl cysts and polyps)Stratum 2, Dose Level 1 (16 mg/m^2)030
seriousNeoplasms benign, malignant and unspecified (incl cysts and polyps) - other, specifyNeoplasms benign, malignant and unspecified (incl cysts and polyps)Stratum 2, Dose Level 2 (22 mg/m^2)0110
seriousNeoplasms benign, malignant and unspecified (incl cysts and polyps) - other, specifyNeoplasms benign, malignant and unspecified (incl cysts and polyps)Stratum 2, Dose Level 3 (28 mg/m^2)0120
seriousNeoplasms benign, malignant and unspecified (incl cysts and polyps) - other, specifyNeoplasms benign, malignant and unspecified (incl cysts and polyps)Stratum 2, Dose Level 4 (36 mg/m^2)060
seriousAtaxiaNervous system disordersStratum 1, Dose Level 1 (10 mg/m^2)1131
seriousAtaxiaNervous system disordersStratum 1, Dose Level 2 (16 mg/m^2)060
seriousAtaxiaNervous system disordersStratum 2, Dose Level 1 (16 mg/m^2)030
seriousAtaxiaNervous system disordersStratum 2, Dose Level 2 (22 mg/m^2)0110

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02717455/events?page=29